The United Laboratories International Holdings (ULIHF) Stock Forecast & Price Target

Q: What is ULIHF’s average 12-month price target, according to analysts?

Based on analyst ratings, The United Laboratories International Holdings Limited’s 12-month average price target is 2.68.

Q: What is ULIHF’s upside potential, based on the analysts’ average price target?

The United Laboratories International Holdings Limited has 42.36% upside potential, based on the analysts’ average price target.

Q: Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

Q: How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Q: Is ULIHF a Buy, Sell or Hold?

The United Laboratories International Holdings Limited has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.

Q: What is The United Laboratories International Holdings Limited’s price target?

The average price target for The United Laboratories International Holdings Limited is 2.68. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $2.68 ,the lowest forecast is $2.68. The average price target represents 42.36% Increase from the current price of $1.88.

Q: What do analysts say about The United Laboratories International Holdings Limited?

The United Laboratories International Holdings Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

Q: How can I buy shares of ULIHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Compare

20 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ULIHF Analyst Ratings

Moderate Buy

1 Buy

0 Hold

0 Sell

Based on 1 analysts giving stock ratings to

The

United Laboratories International Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ULIHF Stock 12 Month Forecast

Average Price Target

$2.68

▲(42.36% Upside)

Based on 1 Wall Street analysts offering 12 month price targets for The United Laboratories International Holdings in the last 3 months. The average price target is $2.68 with a high forecast of $2.68 and a low forecast of $2.68. The average price target represents a 42.36% change from the last price of $1.88.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","3":"$3","0.75":"$0.75","1.5":"$1.5","2.25":"$2.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":2.6764002000000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$2.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.6764002000000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$2.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.6764002000000002,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.68</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,0.75,1.5,2.25,3],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.875,1.9366461692307693,1.9982923384615385,2.0599385076923076,2.121584676923077,2.183230846153846,2.2448770153846156,2.3065231846153846,2.368169353846154,2.429815523076923,2.4914616923076927,2.5531078615384617,2.614754030769231,{"y":2.6764002000000002,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.875,1.9366461692307693,1.9982923384615385,2.0599385076923076,2.121584676923077,2.183230846153846,2.2448770153846156,2.3065231846153846,2.368169353846154,2.429815523076923,2.4914616923076927,2.5531078615384617,2.614754030769231,{"y":2.6764002000000002,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.875,1.9366461692307693,1.9982923384615385,2.0599385076923076,2.121584676923077,2.183230846153846,2.2448770153846156,2.3065231846153846,2.368169353846154,2.429815523076923,2.4914616923076927,2.5531078615384617,2.614754030769231,{"y":2.6764002000000002,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.27,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.27,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.529,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.366,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.366,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.773,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.621,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.621,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.95,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.875,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.875,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$2.68

Average Price Target$2.68

Lowest Price Target$2.68

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.67

Buy

42.18%

Upside

Reiterated

02/27/26

Huatai Securities Sticks to Its Buy Rating for The United Laboratories International Holdings (ULIHF)

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.27

Buy

20.97%

Upside

Reiterated

11/10/25

The United Laboratories International Holdings (ULIHF) Gets a Buy from First Shanghai Securities

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$1.7

Hold

-9.61%

Downside

Reiterated

09/19/25

David Shang

Jefferies

$2.17→$2.56

Buy

35.93%

Upside

Reiterated

09/05/25

Jefferies Remains a Buy on The United Laboratories International Holdings (ULIHF)

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

Buy

59.51%

Upside

Reiterated

07/10/25

Unknown Analyst

TFI Asset Management

Not Ranked

TFI Asset Management

$2.4

Buy

27.57%

Upside

Reiterated

05/20/25

Ziyi Chen

Goldman Sachs

$1.34→$1.95

Hold

3.92%

Upside

Reiterated

03/26/25

United Laboratories Int'l Holdings Ltd. (3933:HK) (ULIHF) PT Raised to HK$15.29 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on United Laboratories Int'l Holdings Ltd. (3933:HK) (OTC: ULIHF) to HK$15.29 (from HK$10.50) while maintaining a Neutral rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Huatai Securities

Not Ranked

Huatai Securities

$2.67

Buy

42.18%

Upside

Reiterated

02/27/26

Huatai Securities Sticks to Its Buy Rating for The United Laboratories International Holdings (ULIHF)

Unknown Analyst

First Shanghai Securities

Not Ranked

First Shanghai Securities

$2.27

Buy

20.97%

Upside

Reiterated

11/10/25

The United Laboratories International Holdings (ULIHF) Gets a Buy from First Shanghai Securities

Unknown Analyst

Morgan Stanley

Not Ranked

Morgan Stanley

$1.7

Hold

-9.61%

Downside

Reiterated

09/19/25

David Shang

Jefferies

$2.17→$2.56

Buy

35.93%

Upside

Reiterated

09/05/25

Jefferies Remains a Buy on The United Laboratories International Holdings (ULIHF)

Unknown Analyst

Guotai Haitong

Not Ranked

Guotai Haitong

Buy

59.51%

Upside

Reiterated

07/10/25

Unknown Analyst

TFI Asset Management

Not Ranked

TFI Asset Management

$2.4

Buy

27.57%

Upside

Reiterated

05/20/25

Ziyi Chen

Goldman Sachs

$1.34→$1.95

Hold

3.92%

Upside

Reiterated

03/26/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering The United Laboratories International Holdings

3 Months

xxx

Success Rate

1/2 ratings generated profit

Average Return

-6.20%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -6.20% per trade.

1 Year

xAi Drug Manufacturers - Specialty and GenericTipRanks - xAI

Success Rate

0/1 ratings generated profit

Average Return

-7.00%

reiterated a buy rating 4 months ago

Copying xAi Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.00% per trade.

2 Years

xxx

Success Rate

0/2 ratings generated profit

Average Return

-12.20%

reiterated a xxx

rating 6 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -12.20% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ULIHF Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ULIHF has received 7 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. ULIHF average Analyst price target in the past 3 months is 2.68.

Each month's total comprises the sum of three months' worth of ratings.

ULIHF Financial Forecast

ULIHF Earnings Forecast

Next quarter’s earnings estimate for ULIHF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was $0.15. ULIHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.

ULIHF Sales Forecast

Next quarter’s sales forecast for ULIHF is $749.50M with a range of $749.50M to $749.50M. The previous quarter’s sales results were $1.03B. ULIHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.

ULIHF Stock Forecast FAQ

What is ULIHF’s average 12-month price target, according to analysts?

Based on analyst ratings, The United Laboratories International Holdings Limited’s 12-month average price target is 2.68.

What is ULIHF’s upside potential, based on the analysts’ average price target?

The United Laboratories International Holdings Limited has 42.36% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ULIHF a Buy, Sell or Hold?

The United Laboratories International Holdings Limited has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.

What is The United Laboratories International Holdings Limited’s price target?

The average price target for The United Laboratories International Holdings Limited is 2.68. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.68 ,the lowest forecast is $2.68. The average price target represents 42.36% Increase from the current price of $1.88.

What do analysts say about The United Laboratories International Holdings Limited?

The United Laboratories International Holdings Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of ULIHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

The United Laboratories International Holdings (ULIHF) Stock Forecast & Price Target

ULIHF Analyst Ratings

ULIHF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering The United Laboratories International Holdings

ULIHF Analyst Recommendation Trends

ULIHF Financial Forecast

ULIHF Earnings Forecast

ULIHF Sales Forecast

ULIHF Stock Forecast FAQ

Detailed List of Analyst Forecasts